4AB:FRA
AbbVie Common Stock
267,80 €
arrow_upward
+0,87%(+2,30) 1D
12-ноя., 22:00:00 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
265,90 €
High
268,70 €
Low
265,60 €
Mkt. cap
520,47 млд
Avg. vol.
96,00
Volume
158,00
52-wk high
272,30 €
52-wk low
167,55 €
No. of employees
57 миң
Open
265,90 €
High
268,70 €
Low
265,60 €
Mkt. cap
520,47 млд
Avg. vol.
96,00
Volume
158,00
52-wk high
272,30 €
52-wk low
167,55 €
No. of employees
57 миң
News stories
From web sources and news partners
NewsBreak: Local News & Alerts
·
4 саат мурун
3 Pharmaceutical Stocks That Offer Safety and Growth
Yahoo Finance
·
5 саат мурун
How Did AbbVie's Immunology Franchise Fare in Q3?
Yahoo Finance
·
6 саат мурун
AbbVie Deal Altering The Investment Case For Nxera Pharma Stock (TSE:4565)?
Trefis
·
7 саат мурун
Could AbbVie Stock Survive A Skyrizi And Rinvoq Slowdown?
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57 миң
Founded2012-ж., 10-апр.
HeadquartersСевер Чикаго, Иллинойс, Америка Кошмо Штаттары
SectorHealth Care
Industry-
Websiteabbvie.com